Abstract
Background:
Aggregatibacter actinomycetemcomitans (A.actinomycetemcomitans) is an anaerobic bacterium has been frequently associated with aggressive periodontitis. Photodynamic therapy (PDT) is a medical treatment to prevent infection progression that utilizes light to activate a photosensitizing agent. Doxycycline is an antibacterial having photosensitivity. This study aimed to evaluate potential doxycycline as an antibacterial and photosensitizer combine PDT against A.actinomycetemcomitans bacteria.
Material and methods:
Samples were distributed to 4 groups as follow: (1) Groups A treated with a diode laser, (2) Group B treated with doxycycline 0,1% and laser, (3) Group C treated only with Doxycycline 0.1%, and (4) Group D no exposure doxycycline/laser. Data were analyzed by one-way ANOVA and Tukey’s HSD test at 5% significance level.
Results:
In this study, doxycycline 0.1% has the effect of reducing the bacterial viability of (59.60±3.26%). Whereas laser exposure 120 s combined with doxycycline produce the effect of bacterial viability reduction (88.50±2.83%) is not significantly different from the effect of laser 120 s exposure (88.79±2.60%). In clinical treatment, the application of laser exposure is generally at the duration of the exposure time of 30 s. The results of this study indicate that the duration of laser exposure 30 s shows a reduction in bacterial viability (44.91±1.69%) equal to the laser and with a combination of doxycycline and laser exposure (70.70±2.43%). So at low doses of laser exposure, doxycycline 0.1% combined with the laser results in the greatest reduction in bacterial viability, significantly different from laser exposure alone.
Conclusion:
at low doses of laser exposure (30s with energy 3.68 J/cm2), doxycycline 0.1% combined with the laser results in the greatest reduction in bacterial viability, significantly different with laser exposure alone.
Keywords: Photodynamic therapy, doxycycline, Aggregatibacter actinomycetemcomitans
Introduction
Aggressive periodontitis is an infectious disease its association rapidly progressing. These patients require treatment to prevent further progression of the disease and tissue damage. Aggregatibacter actinomycetemcomitans (A.actinomycetemcomitans) has an important key to the development of aggressive periodontitis (Lai et al., 2013). A. actinomycetemcomitans has several virulence factors to invade epithelial cells, resisting phagocytosis, and produce leukotoxin and cytolethal descending toxin (Curtis et al., 2011)
Scaling and root planning has been regarded as a standard treatment for periodontitis. However, the treatments cannot produce clinical improvement, especially in cases of advanced disease and periodontal pockets inside, due to no considerable changes in subgingival microbial composition and they do not have to target specific bacterial species. Actinomyces species was the first bacteria that colonized after scaling and root planning procedure, then continuing by higher numbers and a larger proportion of pathogenic bacteria from red and orange group bacteria by slower recolonization (Brayton et al., 2002). Mechanical debridement leaves a large number of pathogenic microorganisms in relatively inaccessible areas, and cause a disturbance on subgingival flora.
Treatment of periodontitis using local antibiotics was intended as an adjunct to non-surgical treatment and to kill pathogenic bacteria from subgingival and extra crevicular niches. Various methods used as antimicrobial agents include rinsing, irrigation, systemic administration, and local applications using the sustained and controlled delivery (Sgolastra et al., 2013). Systemic administration allows antimicrobial agents to reach all periodontal and oral sites. However, the drug effect in the periodontal pocket is relatively low and raises the risk of side effects on non-oral sites of the body. Drugs may also be used as mouth rinses and for subgingival irrigation, but the depth of drugs penetration to the periodontal pocket is limited. Oral irrigation cannot facilitate drug penetration into the deepest area of the pocket. Self-irrigation may be limited by low patient compliance. Therefore, many studies have assessed the effect of local antiseptics and antibiotics only as adjunctive therapy for a periodontal case.
Local antimicrobial therapy is generally used during the maintenance phase to treat any remaining bacteria that isolated by the active pocket. Systemic antibiotics produce adverse drug reactions, uncontrolled patient compliance, and low drug concentrations in the subgingival sites. Local delivery is controlled from within the periodontal pocket.Single administration of antibacterial agent in small amount can maintain therapeutic concentrations in the gingival sulcus fluid for a longer period than other modes of delivery (de Melo et al., 2013). Doxycycline is a derivate of tetracycline, which is effective against A.actinomycetemcomitans. The A.actinomycetemcomitans has resistance 8.9% to doxycycline. Aggressive periodontitis is a progressive disorder of periodontal tissues, it is characterized by the rapid loss of connective tissue attachment and alveolar bone crushing on more than one permanent tooth. A.actinomycetemcomitans bacteria were the most dominant microorganisms found in patients with subgingival aggressive periodontitis bacteria and it is prevalent in Indonesia (Setiawatie et al., 2016).
Administration of local doxycycline produces anti-inflammation effects by inhibition of nuclear factor kappa β in the oral epithelium. Doxycycline can kill bacteria A.actinomycetemcomitans in the epithelial cells, and intracellular accumulation of doxycycline may combat invasive bacteria from the gingival epithelium (Moslemi et al., 2012). However, the disadvantage of doxycycline administration is photosensitivity effect on UV-A (Peacock et al., 2000). New treatments of periodontal disease are needed to prevent the progress of the infection. Doxycycline having photosensitivity effect may have a probability as a photosensitizer. Evaluation of the effective therapy was carried out as the advent of new technologies. Laser therapy, able to call by photodynamic therapy, is increasingly popular treatment, which offers an alternative and selective efficacy. Light therapy is based on the observation that periodontopathic bacteria capable of synthesizing chromophores, such as porphyrin. An in vitro study showed that blue light activation of the porphyrin caused structural damage in A.actinomycetemcomitans membranes and cause cell death. Illumination of the blue light laser (407-420 nm) was able to decrease bacterial growth after 24 hours (Séguier et al., 2010; Choi et al., 2012). This research aimed to evaluate potential doxycycline on A.actinomycetemcomitans (ATCC 43718, USA) bacteria as photosensitizer combine PDT with the blue laser diode.
Materials and Methods
Bacterial Strain and Culture Condition
A strain bacteria was used Aggregatibacter actinomycetemcomitans (ATCC 43718, USA) which grown on Tryptic Soy Agar (TSA) solution (Oxoid CM0131, UK). Isolate bacteria were taken 1 inoculating loop and placed on Tryptic Soy Broth (TSB) solution (Merck Millipore, Germany). Culture was placed on anaerobic jar and saved on incubator CO2 37°C until formed suspense bacteria ~1010 CFU/ml or 0.5 McFarland Standard.
To determine the effect of the antibiotic on these A. actinomycetemcomitans, doxycycline dissolved in sterile water, or sterile water as a control, was injected into each tube and incubated for 30 min. A. actinomycetemcomitans was incubated in Petri dishes. was incubated in Tryptic Soy Agar (TSA) supplemented with 0.5 % yeast extract in the microaerophilic atmosphere at 35ºC for 48 h to obtain strains at exponential growth phase. A. actinomycetemcomitans colony forming units (CFU) were inoculated into Tryptic Soy Broth (TSB) supplemented with 0.5% yeast extract, respectively. Then, 1 mL of CFU of each strain was aspirated with a disposable pipette from the dishes and the volume was dispersed in a sterile 10 mL tube, which was agitated in a tube agitator to spread bacterial strains. This tube was subjected to concentration analysis in a 640 nm spectrophotometer to reach a value between 0.08-0.1 nm corresponding to the final concentration of 1.5 x 108 UFC/mL. Suspense bacteria was taken 0.1 ml after the last dilution and placed on a petri dish and pour TSA solution. Petri dishes were placed on an anaerobic jar and saved on incubator CO2 37°C for 24 hours.
Materials
Doxycycline used in this research was water soluble doxycycline hydrochloride (Doxycycline hyclate; Sigma-Aldrich). Doxycycline 0.1% (w/v) was freshly prepared for each experiment. The absorption spectrum of doxycycline was characterized by UV-Vis spectrophotometer 1800 Shimadzu.
Apparatus Chamber for Illumination
Laser irradiations were carried out using diode lasers. Wavelength and power output will be shown on this result. The experiment design used 6 times exposure variations, 10s, 30s, 50s, 70s, 90s, and 120s.
Treatments
Samples were distributed to 4 groups as follow: (1) Groups A treated with a diode laser, (2) Group B treated with doxycycline 0.1% and laser, (3) Group C treated only with Doxycycline 0.1%, and (4) Group D no exposure doxycycline/laser. Samples were bacterial growth suspense and taken 1 ml on eppendorf. Each group of the experiment was repeated at least 4 times. The number of colony-forming units per milliliter (CFU/ml) was then determined. The results were analyzed by analysis of variance (ANOVA) test. A value of p≤0.05 was considered as a statistically significant difference. Percentage of decrease in the number of bacterial colonies growth defined as:
Results
This study used antibiotics doxycycline, which is generally indicated for people with the infection. However, in this study doxycycline is indicated as a photosensitizer diode laser as a bacterial inactivation agent. Therefore, doxycycline absorbance test using UV-Vis 1800 Series spectrophotometer to know the absorbance spectrum and the length of the wave match between doxycycline with diode laser wavelength were carried out. This absorption test is needed to determine the radiation that microorganisms receive through the absorption results (quantum yield). In this study, the laser used has a wavelength of 409 nm, then at that wavelength absorbance value is obtained which shows the absorbance relationship to the wavelength graph presented in Figure 1.
Figure 1 showed the absorption spectrum of doxycycline. Based on the test results, it can be calculated the ratio of absorbance and transmission to determine the percentage of absorption (Quantum Yield) doxycycline, ie through the equation:
From the calculation, the results obtained that the percentage of doxycycline uptake at 409 nm wavelength is 99.98% which means that the greater the absorbance value of a sample the better the nature of the sample in the absorption. After the percentage of absorption was known, radiation calculations can be performed in Table 1, through the equation:
Table 1.
LaserPower (W) | Area (cm2) | Wave length (nm) | Doxycycline Uptake | Time (s) | Radiation (J/cm2) |
---|---|---|---|---|---|
10 | 1.228 | ||||
30 | 3.684 | ||||
0.049502 | 0.403 | 409 | 0.999898 (99,98%) |
50 | 6.140 |
70 | 8.597 | ||||
90 | 11.053 | ||||
120 | 14.737 |
With R being radiation, P is potency to the radiation distance, A laser beam area, t the time variation used during irradiation, and Q is the quantum yield (% absorption).
Prior to laser diode irradiation of A.actinomycetemcomitans, it is necessary to establish Mc Farl and standard and perform a dilution standard of A.actinomycetemcomitans bacteria first. The results of standard Mc Farl and are shown in Table 2.
Table 2.
OD 595nm | Dilution to- | Sample | Average | CFU/ml | Log CFU/ml | |||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||||
0.44 | 5 | 451 | 578 | 198 | 390 | 404.25 | 8.09x10-7 | 7.908 |
0.54 | 6 | 372 | 424 | 343 | 354 | 373.25 | 7.47x10-8 | 8.873 |
0.59 | 7 | 369 | 190 | 321 | 272 | 288 | 5.76x10-9 | 9.760 |
0.65 | 8 | 128 | 178 | 130 | 124 | 140 | 2.80x10-10 | 10.447 |
Based on Table 2, a Mc Farland standard chart is presented in Figure 3. The graph serves to measure bacterial density optically through ELISA Reader and compare it to the number of bacterial colonies in CFU / ml Log
In Table 2 it is known that the average number of colonies of A.actinoycetemcomitans bacteria with 30-300 colonies requirement is found in the dilution factor of 10-7 (7th dilution) with an OD value of 0.5. After the Mc Farland standard was known, furthermore the dilution standard of the A.actinoycetemcomitans bacteria established presented in Table 3. This dilution standard aims to determine on which dilution is reached the bacterial viability colonies ranges from 30-300 so that the results can be used as a comparison reference to the control group and the treatment group when irradiated using a diode laser.
Table 3.
Dilution to- | Sample | Average | CFU/ml | Log CFU/ml | |||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | ||||
10-5 | 445 | 329 | 418 | 401 | 398.25 | 7.97x107 | 7.90 |
10-6 | 335 | 395 | 431 | 399 | 390.00 | 7.80 x108 | 8.89 |
10-7 | 267 | 294 | 271 | 292 | 281.00 | 5.62 x109 | 9.75 |
10-8 | 148 | 118 | 101 | 132 | 124.75 | 2.50 x1010 | 10.39 |
10-9 | 81 | 83 | 97 | 68 | 82.25 | 1.65 x1011 | 11.21 |
10-10 | 68 | 56 | 47 | 53 | 56.00 | 1.12 x1012 | 12.04 |
In Table 3 it is known that the average number of bacterial colonies in the 7th dilution is 281 colonies, a large number of bacteria is included in the good range of dilution because it is still within the range of 30-300 colonies so that the results obtained the standard dilution of A.actinomycetemcomitans is at the 7th dilution. After performing the Mc Farland standard and obtaining the standard bacterial dilution, the diode laser irradiation is carried out on A.actinomycetemcomitans.
Table 4 shows the viability of bacterial colonies in various treatments. Figure 3 shows the viability of bacterial colonies in various time of diode laser irradiation, with and without doxycycline. Irradiation of diode laser within 120±0,005s decreases the number of A.actinomycetemcomitans by 86.33±3.01%. The viability of bacteria decreases by 69.80±2.91% with the administration of doxycycline. Combination of diode laser irradiation with doxycycline cause the highest decrease in bacterial viability (88.93±2.50%).
Table 4.
Treatments group | Time ex-posure (s) | Laser intensi-ty (J/cm2) | Number of Colonies | CFU/ml | Log CFU/ml | % reduction of viability |
---|---|---|---|---|---|---|
Control | 0 | - | 288 | 5.32E+09 | 9.726 | 0 |
10 | - | 265.75 | 5.76E+09 | 9.760 | 0 | |
30 | - | 269.25 | 5.39E+09 | 9.731 | 0 | |
50 | - | 276.5 | 5.53E+09 | 9.743 | 0 | |
70 | - | 301.25 | 6.03E+09 | 9.780 | 0 | |
90 | - | 303 | 6.06E+09 | 9.782 | 0 | |
120 | - | 259.75 | 5.20E+09 | 9.716 | 0 | |
Laser | 0 | 0.000 | 275.5 | 5.51E+09 | 9.741 | 4.36 |
10 | 1.228 | 157.75 | 3.16E+09 | 9.499 | 42.74 | |
30 | 3.685 | 151.75 | 3.04E+09 | 9.482 | 44.91 | |
50 | 6.141 | 148.5 | 2.97E+09 | 9.473 | 46.28 | |
70 | 8.598 | 142.25 | 2.85E+09 | 9.454 | 48.37 | |
90 | 11.055 | 84.5 | 1.69E+09 | 9.228 | 69.33 | |
120 | 14.740 | 35.5 | 7.10E+08 | 8.851 | 88.50 | |
Doxy | 0 | - | 224.25 | 4.49E+09 | 9.652 | 15.62 |
10 | - | 123.5 | 2.47E+09 | 9.393 | 44.92 | |
30 | - | 114.25 | 2.29E+09 | 9.359 | 49.05 | |
50 | - | 110.75 | 2.22E+09 | 9.345 | 50.61 | |
70 | - | 96.25 | 1.93E+09 | 9.284 | 57.08 | |
90 | - | 91.5 | 1.83E+09 | 9.262 | 59.19 | |
120 | - | 90.5 | 1.81E+09 | 9.258 | 59.64 | |
Laser + Doxy | 0 | 0.000 | 250 | 5.00E+09 | 9.699 | 5.93 |
10 | 1.228 | 104.25 | 2.09E+09 | 9.319 | 58.30 | |
30 | 3.684 | 73.25 | 1.47E+09 | 9.166 | 70.70 | |
50 | 6.140 | 57 | 1.14E+09 | 9.057 | 77.20 | |
70 | 8.597 | 56 | 1.12E+09 | 9.049 | 77.60 | |
90 | 11.053 | 53.75 | 1.08E+09 | 9.031 | 78.50 | |
120 | 14.737 | 28.75 | 5.75E+08 | 8.760 | 88.79 |
The irradiation was done by culturing the isolates of A.actinomycetemcomitans bacteria which were then incubated for 24 hours. For the treatment group, a 0.1% concentration of doxycycline antibiotic was added. Then the irradiation treatment using diode laser is started. At this stage, the sample consisted of 4 treatment groups. Each group consists of six time variations ie 10 s, 30 s, 50 s, 70 s, 90 s, and 120 s. The number of bacterial colonies obtained from diode laser transmission in A.actinomycetemcomitans bacteria presented in Figure 3.
Statistical analysis results in the significant difference between treatments (p<0.05). Group A (laser treatment) has different irradiation in 120 s and has most of decreased. It has a similar pattern to Group B (combine laser and doxycycline). The statistically significant decrease of CFU was found on the diode laser treatment group (Group A and Group B) (p<0.05) compared to the control group. Tukey post hoc test results show that exposure of diode laser with the irradiation time of 120±0.005s produced the highest decrease in the number of A.actinomycetemcomitans 88.79%. It is not significantly different with laser treatment at 120 s. Table 5 shows the results of ANOVA factorial test of the treatments.
Table 5.
Factor | Grup | N | % reduction of bacterial viability | ANOVA Factorial test | ||
---|---|---|---|---|---|---|
average | SD | Sig | conclusion | |||
Laser | Laser 10 s(a) | 4 | 42.74 | 5.49 | p = 0.000 | Significant difference |
Laser s 30 s (ab) | 4 | 44.91 | 1.69 | |||
Laser 50 s(ab) | 4 | 46.28 | 1.90 | |||
Laser 70 s (ab) | 4 | 48.37 | 4.28 | |||
Laser 90 s (abc) | 4 | 69.33 | 3.61 | |||
Laser 120 s (c) | 4 | 88.50 | 2.83 | |||
Total | 72 | 61.76 | 3.26 | |||
Doxy 0.1% | Doxy 10 s (ab) | 4 | 44.92 | 2.50 | p = 0.000 | Significant difference |
Doxy 30 s (ab) | 4 | 49.05 | 3.95 | |||
Doxy 50 s (ab) | 4 | 50.61 | 3.97 | |||
Doxy 70 s (abc) | 4 | 57.08 | 3.05 | |||
Doxy 90 s (abc) | 4 | 59.19 | 3.93 | |||
Doxy 120 s (abc) | 4 | 59.64 | 3.62 | |||
Total | 72 | 61.76 | 3.26 | |||
Laser+Doxy 10 s (abc) | 4 | 58.30 | 3.05 | p = 0.000 | Significant difference | |
Laser+Doxy 30 s (abc) | 4 | 70.70 | 2.43 | |||
Laser+Doxy 50 s (abc) | 4 | 77.20 | 2.03 | |||
Laser Doxy 0.1% | Laser+Doxy 70 s (abc) | 4 | 77.60 | 2.82 | ||
Laser+Doxy 90 s (bc) | 4 | 78.50 | 1.70 | |||
Laser+Doxy 120 s (c) | 4 | 88.79 | 2.60 | |||
Total | 72 | 61.76 | 19.26 |
Discussion
Antibiotics such as doxycycline have been shown to inhibit several matrix metalloproteinases in addition to its antimicrobial activity (Hanem et al., 1998; Ryan et al., 1998; Chang et al., 2010). Doxycycline has disadvantage during treatment because it will be lead photosensitivity on UV-A or 350nm-400nm (Goetze et al., 2017). However, our result has the absorbance of doxycycline reach 410 nm before falling down. It will be an advantage when PDT is combined with the antibiotic. Doxycycline also is known to disrupt the function of mitochondria (Moullan et al., 2015) and produces oxygen species that play a role in the activation procollagenases and progelatinases in vitro (Ramamurthy et al., 1993, Smith et al, 1996). Doxycycline modulates other cellular functions, including proliferation and matrix remodeling (Franco et al., 2006). Our result on treatment provides group doxycycline treatment give decreased more than the control group. Topically administered of doxycycline 0,1% has been used for the treatment of periodontitis without adverse or side effects reaction. Doxycycline appears to be a promising photosensitizer in PDT. This study showed the possibility to kill A.actinomycetemcomitans in vitro by using topically applied doxycycline 0,1% combination with 408 nm diode laser. Doxycycline used at therapeutic concentrations do not have toxicity but after laser exposure, they show phototoxicity. This behavior is caused by their photodegradation products and their reactive nature. The mechanism of cellular damage is associated with an increase of oxidation in biomacromolecules such as albumin (BSA) and RNase A, the cellular damage via oxidation of specific aromatic amino acids. Photoaffinity of studied compounds for albumin and others proteins is related to the different lipophilic proprieties shown for the seven tetracyclines derivatives. Doxycycline is the most phototoxic compound of the series tetracycline (Fuoco, 2015)
Photodynamic therapy (PDT) utilizes visible light (laser) and dye (photosensitizer), which produce free oxygen radicals to selectively destroy bacteria and their by-products. PDT combines non-toxic photoactive dyes and harmless visible light to produce singlet oxygen and free radicals to kill microbial cells. The effectiveness of PDT as assessed by previous studies has been focusing on various microorganisms and photosensitizers. Studies of the susceptibility of A.actinomycetemcomitans to lethal photosensitization in vitro have reported that the organism can be killed with low concentrations of methylene blue and low light energy doses. Methylene blue caused 64% bacterial reduction, therefore seen to be less efficient on A.actinomycetemcomitans (Lang et al., 2009). A more recent study using photosensitizers based on porphyrin skeleton and a red laser showed only 62% reduction of A.actinomycetemcomitans (Andriankaja et al., 2010).
In this study, doxycycline 0.1% has the effect of reducing the bacterial viability of (59.60±3.26%). Whereas laser exposure 120 s combined with doxycycline produce the effect of bacterial viability reduction (88.50±2.83%) is not significantly different from the effect of laser 120 s exposure (88.79±2.60%). In clinical treatment, the application of laser exposure is generally at the duration of the exposure time of 30s. The results of this study indicate that the duration of laser exposure 30 s shows a reduction in bacterial viability (44.91±1.69%) equal to the laser and with a combination of doxycycline and laser exposure (70.70±2.43%). So at low doses of laser exposure, doxycycline 0.1% combined with the laser results in the greatest reduction in bacterial viability, significantly different from laser exposure alone.
Photodynamic Inactivation (PDI) is a method for inactivation in microbes. The combination of light and certain photosensitizer in PDI will cause photoinactivation in bacteria (Wardle, 2009), ie inhibition of cell metabolic activity due to cytoplasmic membrane damage due to peroxidation by reactive oxygen (Hamblin & Hasan, 2003). Photoinactivation mechanism involves the process of photosensitization, which is the process of light absorption by photosensitizer molecules which further activate the chemical reaction produces various species of reactive oxygen. Photosensitization depends on the type and quantity of photosensitizer acting as light-absorbing molecules (Nitzan et al., 2004) and the suitability of the light spectrum with the photosensitivity absorptive spectrum (Papageorgiou et al., 2000). At the molecular level due to irradiation begins with a photophysical event of light absorption which further activates photosensitizer molecules, followed by photochemical reactions that produce various species of reactive oxygen (Plaetzer et al., 2009). Reactive oxygen causes lipid peroxidation in cell, lysis or inactivation of membrane transport systems in these bacterial cells, and bacterial cell damage (Hamblin & Hasan, 2003).
The success of photodynamic therapy depends on the suitability of the light source wavelength spectrum with the photosensitizer absorption spectrum. In this study the absorption spectrum of doxycycline at 408 nm, while the laser light source used 409 nm. So doxycycline as photosensitizer able to absorb (quantum yield) the laser light energy 99.99%. Bacterial reduction differs depending on the quantum yield density of photosensitizer.To determine effective dose treatment of PDT is difficult because concentration photosensitizer and light absorption have certain measurement (Hegge et al., 2012). High light energy may be not enough to decreased bacteria caused quantum molecular process.The lower light energy doses used (6 and 12 J), the extent of bacterial killing increased markedly as the photosensitizer concentration increased. The results imply that even at the lowest light energy dose used (6 J), enough photons were being supplied to activate all of the photosensitizer molecules present (resulting from the application of 0,1% of doxycycline to release sufficient ROS) to enable the killing of most (approximately 90%) bacteria present. The killing of bacteria with the light energy dose was limited by the concentration of the photosensitizer at the site or, more strictly, its ROS-generating capacity.
Local antimicrobial agents should be applied in the treatment of periodontitis (Bernhart et al., 2016). However, it is difficult to maintain the level of therapeutic agents for a long time due to elution agent by the gingival crevicular fluid. To resolve this problem, fiber insertion, strip, and resorbable cellulose that release agent slowly into the periodontal pocket have been used (Kim et al., 2015). Biodistribution of topically applied doxycycline on the gingival structures showed penetration by photosensitizer throughout the epithelium. Following subsequent illumination, the photodynamic effect was limited to the epithelium. When the highest concentration was used, the most intense fluorescence throughout the epithelial layer is observed, but the intensity of fluorescence in the connective tissue is very low. Penetration throughout the epithelium and connective tissues may be important, as periodontopathogens can infiltrate through the epithelial barrier into the connective tissue (Marchetti et al., 2012). PDT can possibly eliminate bacteria that have migrated to the tissue. The use of PDT is not affected by such problem, since the photosensitizer administration into periodontal pocket only needs a short time; maybe minutes or even seconds, depending on light source intensity used (Gursoy et al., 2013)This study showed that 0.1% of doxycycline reduces the number of A.actinomycetemcomitans below detectable level within only 30 s exposure. Compared to conventional therapy, adjunctive therapy encompasses new technologies and office procedures such as light and laser therapy, photodynamic therapy. The demand for adjunctive therapy arises from the desire for more effective and quicker therapy.
Conclusions
In this study, doxycycline 0.1% has the effect of reducing the bacterial viability of (59.60±3.26%). Whereas laser exposure 120 s combined with doxycycline produce the effect of bacterial viability reduction (88.50±2.83%) is not significantly different from the effect of laser 120 s exposure (88.79±2.60%). In clinical treatment, the application of laser exposure is generally at the duration of the exposure time of 30s. The results of this study indicate that the duration of laser exposure 30 s shows a reduction in bacterial viability (44.91±1.69%) equal to the laser and with a combination of doxycycline and laser exposure (70.70±2.43%). So at low doses of laser exposure, doxycycline 0.1% combined with the laser results in the greatest reduction in bacterial viability, significantly different from laser exposure alone.
Footnotes
Conflict of Interest: The authors report no conflict of interest and the article is not funded or supported by any research grant.
References
- 1.Andriankaja OM, Sreenivasa S, Dunford R, DeNardin E. Association between metabolic syndrome and periodontal disease. Aust Dent J. 2010;55:252–259. doi: 10.1111/j.1834-7819.2010.01231.x. doi:10.1111/j.1834-7819.2010.01231.x. [DOI] [PubMed] [Google Scholar]
- 2.Bernhart T, Mailath-pokorny G. Lethal photosensitization for decontamination of implant surfaces in the treatment of peri-implantitis Lethal photosensitization for decontamination of implant surfaces in the treatment of peri-implantitis. 2016;2016 doi: 10.1034/j.1600-0501.2001.012002104.x. doi:10.1034/j.1600-0501.2001.012002104.x. [DOI] [PubMed] [Google Scholar]
- 3.Brayton JJ, Yang Qing Y, Nakkula Robin J, MS1, WJDW An in vitro model of ciprofloxacin and minocycline transport by oral epithelial. Cells. 2002;73(11):1267–1272. doi: 10.1902/jop.2002.73.11.1267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chang WY, Clements D, Johnson SR. Effect of doxycycline on proliferation, MMP production, and adhesion in LAM-related cells. Am J Physiol Lung Cell Mol Physiol. 2010;299(3):L393–400. doi: 10.1152/ajplung.00437.2009. doi:10.1152/ajplung.00437.2009. [DOI] [PubMed] [Google Scholar]
- 5.Choi K-H, Lee H-J, Park BJ, Wang K.K, Shin E.P, Park J.C, Kim Y.K, Oh M.K, Kim Y.R. Photosensitizer and vancomycin-conjugated novel multifunctional magnetic particles as photoinactivation agents for selective killing of pathogenic bacteria. Chem Commun (Camb) 2012;48(38):4591–4593. doi: 10.1039/c2cc17766h. doi:10.1039/c2cc17766h. [DOI] [PubMed] [Google Scholar]
- 6.Curtis MA, Zenobia C, Darveau RP. The Relationship of the Oral Microbiotia to Periodontal Health and Disease. Cell Host Microbe. 2011;10(4):302–306. doi: 10.1016/j.chom.2011.09.008. doi:10.1016/j.chom.2011.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.De Melo WC, Avci P, de Oliveria MN, Gupta A, Vecchio D, Sadasivam M, Chandran R, Huang YY, Yin R, Perussi L.R, Tegos G.P, Perussi J.R, Dai T, Hamblin M.R. Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection. Expert Rev Anti Infect Ther. 2013;11(7):669–693. doi: 10.1586/14787210.2013.811861. doi:10.1038/nature13314.A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Franco C, Ho B, Mulholland D, Hou G, Islam M, Donalson K, Bendeck M.P. Doxycycline Alters Vascular Smooth Muscle Cell Adhesion, Migration, and Reorganization of Fibrillar Collagen Matrices. Am J Pathol. 2006;168(5):1697–1709. doi: 10.2353/ajpath.2006.050613. doi:10.2353/ajpath.2006.050613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fuoco D. Cytotoxicity Induced by Tetracyclines via Protein Photooxidation Advances in Toxicology. Hindawi Publishing Corporation. 2015 http://dx.doi.org/10.1155/2015/787129 .
- 10.Goetze S, Hiernickel C, Elsner P. Phototoxicity of Doxycycline : A Systematic Review on Clinical Manifestations, Frequency, Cofactors, and Prevention. Ski. Pharmacol Physiol. 2017;30:76–80. doi: 10.1159/000458761. [DOI] [PubMed] [Google Scholar]
- 11.Gursoy H, Ozcakir-Tomruk C, Tanalp J, Yilmaz S. Photodynamic therapy indentistry: A literature review. Clin Oral Investig. 2013;17(4):1113–1125. doi: 10.1007/s00784-012-0845-7. doi:10.1007/s00784-012-0845-7. [DOI] [PubMed] [Google Scholar]
- 12.Hanemaaijer R, Visser H, Koolwijk P, Sorsa T, Salo T, Golub L.M, Van Hinsbergh V.W.M. Inhibition of MMP Synthesis by Doxycycline and Chemically Modified Tetracyclines (CMTs) in Human Endothelial Cells. Adv Dent Res. 1998;12(1):114–118. doi: 10.1177/08959374980120010301. doi:10.1177/08959374980120010301. [DOI] [PubMed] [Google Scholar]
- 13.Hamblin MR, Hasan T. Photodynamic Therapy: a New Antimicrobial Approach to Infectious Disease? Journal of Photochem and Photobio B: Biology Science. 2003;3:436–450. doi: 10.1039/b311900a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hegge AB, Bruzell E, Kristensen S, Tonnesen HH. Photoinactivation of Staphylococcus epidermidis biofilms and suspensions by the hydrophobic photosensitizer curcumin - Effect of selected nanocarrier: Studies on curcumin and curcuminoides XLVII. Eur. J. Pharm. Sci. 2012;47:65–74. doi: 10.1016/j.ejps.2012.05.002. [DOI] [PubMed] [Google Scholar]
- 15.Kim J, Kim S, Choi H, Kim O. Effects of the antimicrobial peptide cathelicidin (LL-37) on immortalized gingival fibroblasts infected with Porphyromonas gingivalis and irradiated with 625-nm. LED light. 2015;30(8):2049–2057. doi: 10.1007/s10103-014-1698-x. [DOI] [PubMed] [Google Scholar]
- 16.Lai PC, Walters JD. Azithromycin kills invasive aggregatibacter actinomycetemcomitans in gingival epithelial cells. Antimicrob Agents Chemother. 2013;57(3):1347–1351. doi: 10.1128/AAC.02558-12. doi:10.1128/A.ACTINOMYCETEMCOMITANSC.02558-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lang NP, Schätzle MA, Löe H. Gingivitis as a risk factor in periodontal disease. J Clin Periodontol. 2009;36(10):3–8. doi: 10.1111/j.1600-051X.2009.01415.x. doi:10.1111/j.1600-051X.2009.01415.x. [DOI] [PubMed] [Google Scholar]
- 18.Marchetti E, Monaco A, Procaccini L, Mummolo S, Gatto R, Tete S, Baldini A, Tecco S, Marzo G. Periodontal disease: the influence of metabolic syndrome. Nutr Metab (Lond) 2012;9(1):88. doi: 10.1186/1743-7075-9-88. doi:10.1186/1743-7075-9-88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Moslemi N, Heidari M, Bouraima SA. Antimicrobial Photodynamic Therapy as an Adjunctive Modality in the Treatment of Chronic Periodontitis.; Journal of Lasers in Med. Sci. 2012;3(4):141–146. [Google Scholar]
- 20.Moullan N, Mouchiroud L, Wang X, Ryu D, William E.G, Mottis A, Jovaisaite V, Frochaux M.V, Quiros P.M, Deplancke B, Houtkooper R.H, Auwerx J. Tetracyclines disturb mitochondrial function across eukaryotic models: A call for caution in biomedical research. Cell Rep. 2015;10(10):1681–1691. doi: 10.1016/j.celrep.2015.02.034. doi:10.1016/j.celrep.2015.02.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Nitzan Y, Divon M.S, Shporen E, Malik Z. ALA Induced Photodynamic Effect on Gram Positive and Negative Bacteria. Journal of Photochemistry and Photobiology P: Physics. 2004;3:430–435. doi: 10.1039/b315633h. [DOI] [PubMed] [Google Scholar]
- 22.Papageorgiou Katsambas A, Chu A. Phototherapy with Blue (415nm) and Red (660nm) Light in The Treatment of Acne Vulgaris. British Journal of Dermatology. 2000;142:973–978. doi: 10.1046/j.1365-2133.2000.03481.x. [DOI] [PubMed] [Google Scholar]
- 23.Peacock DL, Frcp C, Wong LTK, Frcp C, Davidson AGF, Frcp C. An Unusual Presentation of Doxycycline-Induced Photosensitivity. Pediatrics. 2000:106. doi: 10.1542/peds.106.1.e13. [DOI] [PubMed] [Google Scholar]
- 24.Plaetzer K, Krammer B, Berlanda J, Berr F. Photophysics and Photochemistry of Photodynamic Therapy: Fundamental Aspects. Journal of Laser Medical Sciences. 2009;24:259–268. doi: 10.1007/s10103-008-0539-1. [DOI] [PubMed] [Google Scholar]
- 25.Ramamurthy NS, Vernillo A.T, Greenwald R.A, Lee H.M, Sorsa T, Golub L.M, Rifkin B.R. Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J Bone Miner Res. 1993;8(10):1247–1253. doi: 10.1002/jbmr.5650081013. doi:10.1002/jbmr.5650081013. [DOI] [PubMed] [Google Scholar]
- 26.Ryan ME, Ashley RA. How do tetracyclines work? Adv Dent Res. 1998;12(2):149–151. doi: 10.1177/08959374980120011101. doi:10.1177/08959374980120011101. [DOI] [PubMed] [Google Scholar]
- 27.Séguier S, Souza SLS, Sverzut ACV, Simioni A.R, Primo F.L, Bodineau A, Correa V.M.A, Coulomb B, Tedesco A.T. Impact of photodynamic therapy on inflammatory cells during human chronic periodontitis. J Photochem Photobiol B Biol. 2010;101(3):348–354. doi: 10.1016/j.jphotobiol.2010.08.007. doi:10.1016/j.jphotobiol.2010.08.007. [DOI] [PubMed] [Google Scholar]
- 28.Setiawatie EM, Astuti SD, Zaidan AH. An in vitro Anti-microbial Photodynamic Therapy (aPDT) with Blue LEDs to Activate Chlorophylls of Alfalfa Medicago sativa L on Aggregatibacter actinomycetemcomitans. J Int Dent Med Res. 2016;9(2):118–125. [Google Scholar]
- 29.Sgolastra F, Petrucci A, Gatto R, Marzo G, Monaco A. Photodynamic therapy in the treatment of chronic periodontitis: A systematic review and meta-analysis. Lasers Med Sci. 2013;28(2):669–682. doi: 10.1007/s10103-011-1002-2. doi:10.1007/s10103-011-1002-2. [DOI] [PubMed] [Google Scholar]
- 30.Smith GN, Brandt KD, Hasty KA. Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity. Arthritis Rheum. 1996;39(2):235–244. doi: 10.1002/art.1780390209. doi:10.1002/art.1780390209. [DOI] [PubMed] [Google Scholar]